Our Platforms
Our Platforms
Back- iPSCs as cancer vaccines
- Cell therapies with iPSC-CMs for cardiovascular disease
- iPSC-CMs for drug discovery and cardiotoxicity screening
iPSC BIOBANK
The world's largest library of human iPSCs
Our biobank enables the acceleration of drug discovery and development in many diseases
Learn moreLITERATURE
- Khloris Biosciences Presents at SITC 2023: Both Allogeneic and Syngeneic induced Pluripotent Stem Cell (iPSC) Vaccines Decrease Tumor Growth and Improve Survival in a Prophylactic Mouse Model of Breast Cancer Learn more
- Khloris Biosciences Presents at SITC 2023: Efficacy and Immunogenicity of Induced Pluripotent Stem Cell (iPSC) Vaccine is Independent of iPSC Viability in a Prophylactic Mouse Model of Breast Cancer Learn more
- Khloris Biosciences presents at SITC 2021: An induced pluripotent stem cell (iPSC) vaccine decreases tumor growth and improves survival in a therapeutic mouse model of colon cancer Learn more
- Khloris Biosciences presents at SITC 2021: An induced pluripotent stem cell (iPSC) vaccine is highly immunogenic and reduces lung metastases in a mouse model of melanoma Learn more